IC
MRNA icon

IEQ Capital’s Moderna MRNA Stock Holding History

IEQ Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$662K Buy
+9,448
New +$489K ﹤0.01% 1278
2025
Q3 		– Sell
-7,795
Closed -$215K – 1996
2025
Q2 		$215K Buy
+7,795
New +$205K ﹤0.01% 1580
2025
Q1 		– Sell
-7,194
Closed -$299K – 1688
2024
Q4 		$299K Buy
+7,194
New +$344K ﹤0.01% 1027
2024
Q3 		– Sell
-15,998
Closed -$1.9M – 1185
2024
Q2 		$1.9M Buy
15,998
+5,668
+55% +$717K 0.03% 351
2024
Q1 		$1.1M Buy
10,330
+1,637
+19% +$165K 0.02% 442
2023
Q4 		$865K Buy
8,693
+3,326
+62% +$280K 0.01% 458
2023
Q3 		$554K Sell
5,367
-1,359
-20% -$152K 0.01% 538
2023
Q2 		$817K Sell
6,726
-1,969
-23% -$263K 0.02% 442
2023
Q1 		$1.34M Buy
8,695
+608
+8% +$100K 0.03% 330
2022
Q4 		$1.45M Sell
8,087
-2,207
-21% -$361K 0.04% 296
2022
Q3 		$1.22M Buy
10,294
+3,859
+60% +$586K 0.03% 321
2022
Q2 		$919K Buy
6,435
+38
+0.6% +$5.43K 0.03% 323
2022
Q1 		$1.1M Buy
6,397
+917
+17% +$154K 0.03% 313
2021
Q4 		$1.39M Sell
5,480
-400
-7% -$117K 0.03% 251
2021
Q3 		$2.26M Buy
5,880
+2,622
+80% +$967K 0.06% 167
2021
Q2 		$766K Buy
3,258
+1,122
+53% +$201K 0.02% 291
2021
Q1 		$280K Buy
+2,136
New +$310K 0.01% 378
2020
Q4 		– Sell
-2,875
Closed -$203K – 328
2020
Q3 		$203K Buy
+2,875
New +$200K 0.01% 365

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

IEQ Capital's MRNA Position: Q2 2026 in Review

IEQ Capital opened a new position in Moderna (MRNA) in Q2 2026: 9,448 shares worth $662K. The stake represents ﹤0.01% of the portfolio and ranks #1278 among its holdings. This is a return to the name: IEQ Capital previously reported a position in MRNA as recently as Q2 2025.

IEQ Capital first reported a position in MRNA in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.26M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • IEQ Capital held 9,448 shares of Moderna worth $662K as of Q2 2026.
  • Moderna was a new IEQ Capital position in Q2 2026.
  • Moderna made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1278 holding.
  • IEQ Capital first reported a position in Moderna in Q3 2020 and has held it in 18 quarters since.
  • IEQ Capital's Moderna position peaked at $2.26M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.